GSK2982772 |
GSK2982772 : Inhibitor of RIPK1
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| RIPK1 |
|
|
Inhibitor
up to 300 nM
Selectivity
In Vitro Selectivity Assessment
Selectivity Assessment Description:
GSK2982772 shows more than 1,000-fold selectivity for ERK5 over a panel of over 339 kinases React ...
In Cell Selectivity Assessment
Selectivity Assessment Description:
GSK2982772 demonstrated a clean profile against a range of nonkinase targets. No inhibitory poten ...
Potency Cellular
In Vitro
RIPK1
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1021/acs.jmedchem.6b01751
In Vivo Validations
Rat, Monkey
Dose: 1.1 (R) - 1.2 (M) mg/Kg, 2.1 (R) - 1.9 (M) mg/Kg, Reviewer suggested 5-50 mg/Kg PO
Route of delivery:
Intravenous, Oral
Plasma half life:
3.9 ± 0.7 (R), 6.5 ± 1.0 (M) h (IV)
Systemic clearance:
17 ± 5 (R), 10 ± 3(M) ml/min/Kg (IV)
DOI Reference: 10.1021/acs.jmedchem.6b01751
Orthogonal Probes def
GSK481
Chemical Information
| Molecular Formula | C20H19N5O3 |
| SMILEs | CN1C(=O)[C@@H](NC(=O)c2n[nH]c(Cc3ccccc3)n2)COc2ccccc21 |
| InChI | InChI=1S/C20H19N5O3/c1-25-15-9-5-6-10-16(15)28-12-14(20(25)27)21-19(26)18-22-17(23-24-18)11-13-7-3-2-4-8-13/h2-10,14H,11-12H2,1H3,(H,21,26)(H,22,23,24)/t14-/m0/s1 |
| Molecular weight | 377.15 Da |
| AlogP | 1.5492999999999992 |
| HBond acceptors | 8 |
| HBond donors | 2 |
| Atoms | 47 |
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.